Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance by David A. Schoenfeld, Ross D. Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar, Lucia Jilaveanu, Michael Hurwitz, David L. Rimm, Harriet M. Kluger

Subjects: “…LAG3…”
Get full text

LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies by Marc Emmenegger, Elena De Cecco, Marian Hruska‐Plochan, Timo Eninger, Matthias M Schneider, Melanie Barth, Elena Tantardini, Pierre de Rossi, Mehtap Bacioglu, Rebekah G Langston, Alice Kaganovich, Nora Bengoa‐Vergniory, Andrès Gonzalez‐Guerra, Merve Avar, Daniel Heinzer, Regina Reimann, Lisa M Häsler, Therese W Herling, Naunehal S Matharu, Natalie Landeck, Kelvin Luk, Ronald Melki, Philipp J Kahle, Simone Hornemann, Tuomas P J Knowles, Mark R Cookson, Magdalini Polymenidou, Mathias Jucker, Adriano Aguzzi

Subjects: “…LAG3…”
Get full text

A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B‐cell lymphoma by Hyunjee Lee, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Junhun Cho

Subjects: Get full text

Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials by Ke Ren, Hayam Hamdy, Abdo Meyiah, Eyad Elkord, Eyad Elkord, Eyad Elkord

Subjects: Get full text

Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer by Anne-Sophie Heimes, Katrin Almstedt, Slavomir Krajnak, Anne Runkel, Annika Droste, Roxana Schwab, Kathrin Stewen, Antje Lebrecht, Marco J. Battista, Walburgis Brenner, Annette Hasenburg, Mathias Gehrmann, Jan G. Hengstler, Marcus Schmidt

Subjects: “…LAG-3…”
Get full text

LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections by Linmar Rodríguez-Guilarte, Mario A. Ramírez, Catalina A. Andrade, Alexis M. Kalergis

Subjects: “…LAG-3…”
Get full text

Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review by Yingzhe Luo, Xuebin Cai, Biao Yang, Facheng Lu, Cheng Yi, Guoyu Wu

Subjects: “…LAG-3…”
Get full text

The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanoma by Melanie Wiecken, Devayani Machiraju, Shounak Chakraborty, Eva-Maria Mayr, Bénédicte Lenoir, Rosa Eurich, Jasmin Richter, Nicole Pfarr, Niels Halama, Jessica C. Hassel

Subjects: Get full text

PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy by Christopher D. Zahm, Jena E Moseman, Lauren E. Delmastro, Douglas G. Mcneel

Subjects: Get full text

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies by Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud

Subjects: Get full text

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application by Huo, Jin-Ling, Wang, Ya-Tao, Fu, Wen-Jia, Lu, Nan, Liu, Zhang-Suo

Subjects: Get full text

Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements by Alejandra Martínez-Pérez, Rocío Granda-Díaz, Candelaria Aguilar-García, Christian Sordo-Bahamonde, Segundo Gonzalez

Subjects: Get full text

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy by Letong Cai, Yuchen Li, Jiaxiong Tan, Ling Xu, Yangqiu Li

Subjects: “…LAG-3…”
Get full text

Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression by Jianchu Wang, Wang Wei, Qianli Tang, Libai Lu, Zongjiang Luo, Wenchuan Li, Yuan Lu, Jian Pu

Subjects: “…anti‐Lag‐3…”
Get full text

PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival by Oscar Jimenez, Tamara Mangiaterra, Sandra Colli, Mercedes García Lombardi, Maria Victoria Preciado, Elena De Matteo, Elena De Matteo, Paola Chabay

Subjects: Get full text

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pat... by Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, Mohd. Farooq Shaikh, Christina Piperi

Subjects: “…LAG3…”
Get full text

Diminished LAG3+ B cells correlate with exacerbated rheumatoid arthritis by Suiyuan Hu, Yuting Tao, Fanlei Hu, Xu Liu

Subjects: Get full text

PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity by Haiping Jiang, Haiqing Ni, Pan Zhang, Xiaoli Guo, Min Wu, Haoran Shen, Jie Wang, Weiwei Wu, Zhihai Wu, Jiazheng Ding, Rong Tang, Shuaixiang Zhou, Bingliang Chen, Michael Yu, Hua Jing, Junjian Liu

Subjects: Get full text

Bibliometric analysis of evolutionary trajectory and prospective directions of LAG-3 in cancer by Jin Wang, Siying Wang, Yuting Zhang, Wei Zhang

Subjects: Get full text

ПАТОГЕНЕТИЧЕСКОЕ ЗНАЧЕНИЕ LAG-3 У ПАЦИЕНТОВ С КОЛОРЕКТАЛЬНЫМ РАКОМ by А.В. Четверяков, В.Л. Цепелев

Subjects: Get full text